Tulipan Jacob, Abboudi Jack, Wang Mark L, Kwok Moody, Seigerman Daniel, Gallant Greg G, Beredjiklian Pedro
Division of Hand Surgery, Rothman Orthopaedic Institute, Philadelphia, USA.
Orthopaedic Surgery, Rothman Orthopaedic Institute, New York, USA.
Cureus. 2022 Jul 15;14(7):e26886. doi: 10.7759/cureus.26886. eCollection 2022 Jul.
Introduction Tramadol and codeine are both commonly prescribed in the setting of surgery or injury to the upper extremity. Despite their comparable strength in terms of opioid receptor affinity, the drugs differ pharmacologically and thus are not completely interchangeable. Methods This study analyzes all prescriptions for codeine and tramadol by a group of hand surgeons over a one-year period and tests the central hypothesis that the prescribing and refill patterns of these two drugs would be similar. Results Despite similar prescription amounts in terms of morphine equivalents, patients receiving tramadol required prescription refills at a significantly higher amount than those receiving codeine, and these individuals tended to be older. Additionally, patients treated nonoperatively were prescribed significantly more tramadol than those treated surgically. Conclusion Our findings suggest that codeine and tramadol are not equivalent in managing upper extremity pain. Further study is needed to articulate the situations in which physicians and patients are better served by tramadol versus codeine.
引言
曲马多和可待因常用于上肢手术或损伤的治疗。尽管它们在阿片受体亲和力方面强度相当,但这两种药物在药理上存在差异,因此并非完全可互换。
方法
本研究分析了一组手外科医生在一年时间内开具的所有可待因和曲马多处方,并检验了这两种药物的处方和再填充模式相似这一核心假设。
结果
尽管按吗啡当量计算的处方量相似,但接受曲马多治疗的患者所需的处方再填充量显著高于接受可待因治疗的患者,而且这些患者往往年龄较大。此外,非手术治疗的患者比手术治疗的患者开具的曲马多显著更多。
结论
我们的研究结果表明,可待因和曲马多在上肢疼痛管理方面并不等效。需要进一步研究以阐明在哪些情况下曲马多比可待因更能使医生和患者受益。